InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
76.73
(
0.53%
)
Bitcoin
58,337.56
(
1.76%
)
Post# of 43312
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ohm20

Send PM Follow Ignore
Followers 46
Posts 2450
Boards Moderated 0
Alias Born 04/17/2019

ohm20

Re: LongTkt post# 11206

Thursday, 07/16/2020 6:26:24 PM

Thursday, July 16, 2020 6:26:24 PM

Post# of 43312

both will likely get FDA approvals very soon based on anecdotal evidence.


The FDA doesn't approve on anecdotal evidence. I haven't been paying attention to where HGEN is in it's latest trial, CYDY will be releasing trial data shortly.

Neither CYDY nor HGEN will be able to fully/solely supply the COVID treatment global demand to calm the cytokine storm.


true

Let's just hope neither company is bought out at current bargain basement prices given the potential revenue from the COVID crisis.



I don't know about Durrant but Pourhassan will dismiss anything that doesn't take into account future potential.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up